"Phosphoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D010750
|
MeSH Number(s) |
D12.776.744
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phosphoproteins".
Below are MeSH descriptors whose meaning is more specific than "Phosphoproteins".
This graph shows the total number of publications written about "Phosphoproteins" by people in this website by year, and whether "Phosphoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2001 | 1 | 1 | 2 |
2002 | 0 | 3 | 3 |
2003 | 4 | 0 | 4 |
2004 | 1 | 0 | 1 |
2005 | 0 | 2 | 2 |
2009 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2013 | 0 | 2 | 2 |
2014 | 1 | 2 | 3 |
2016 | 1 | 0 | 1 |
2017 | 28 | 18 | 46 |
2018 | 22 | 11 | 33 |
2019 | 4 | 5 | 9 |
2020 | 2 | 77 | 79 |
2021 | 0 | 80 | 80 |
To return to the timeline, click here.
Below are the most recent publications written about "Phosphoproteins" by people in Profiles.
-
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection. Clin Chem. 2021 12 30; 68(1):240-248.
-
Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor. J Mol Cell Biol. 2021 12 30; 13(10):763-766.
-
Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA. Virulence. 2021 12; 12(1):1597-1609.
-
Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR. Emerg Microbes Infect. 2021 Dec; 10(1):1148-1155.
-
SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: Frequency and association with inflammatory and tissue-damage biomarkers. J Med Virol. 2022 01; 94(1):222-228.
-
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies. Microbiol Spectr. 2021 10 31; 9(2):e0008721.
-
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct Target Ther. 2021 09 01; 6(1):331.
-
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021 Sep; 71:103561.
-
Incomplete IgG avidity maturation after seasonal coronavirus infections. J Med Virol. 2022 01; 94(1):186-196.
-
Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS-CoV-2 infection. J Med Virol. 2022 01; 94(1):178-185.